Delivery Order SPE2DB22D2007-SPE2DB25FJ2QT
Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,915.65 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Dasatinib 50 mg, a pharmaceutical product commonly used in cancer treatment. This firm fixed price contract was competitively awarded without set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order was executed on May 6, 2025, with an ultimate completion date of May 7, 2025, and...
- The Defense Logistics Agency awarded a $25,721.56 delivery order to AmerisourceBergen Drug Corp for Dasatinib 80 mg tablets in a 30-count supply on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The place...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 6, 2025, for the supply of Dasatinib 80 mg tablets in quantities of 30 units. The contract is valued at $4,479.02 with a firm fixed price structure and an ultimate completion date of August 7, 2025. This award represents a non-set-aside competitive procurement and serves as a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 70 mg tablets (60-count units) under a firm fixed-price contract valued at $4,583.27, with an ultimate completion date of September 29, 2025. This non-set-aside delivery order represents a competitive award to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 140 mg tablets in a quantity of 30 units, with a contract ceiling value of $3,744.14. This competitively awarded, firm fixed-price delivery order was established on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $47,320.66 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Dasatinib 50 mg tablets (60-count units) with a ceiling value of $26,228.57. This firm fixed-price delivery order is set to conclude by September 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,448.37 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) with an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This delivery order, awarded on July 24, 2025, represents a $43,339.66 firm fixed-price contract for 60-count bottles of Dasatinib 50 mg tablets to be delivered to Conshohocken, Pennsylvania. The Defense Logistics Agency awarded this non-competitive delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement. The award is expected to be completed by July 25, 2025, reflecting a rapid fulfillment timeline typical of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dasatinib 20 mg tablets (60-count units) with a ceiling value of $2,077.39. This is a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The contract was competitively awarded with no set-aside designation and is being...